vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Global Business Travel Group, Inc. (GBTG). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $792.0M, roughly 1.2× Global Business Travel Group, Inc.). Global Business Travel Group, Inc. runs the higher net margin — 10.5% vs 7.7%, a 2.8% gap on every dollar of revenue. On growth, Global Business Travel Group, Inc. posted the faster year-over-year revenue change (34.0% vs 13.5%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $13.0M). Over the past eight quarters, Global Business Travel Group, Inc.'s revenue compounded faster (13.9% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
A travel management company (TMC) is a travel agency which manages organizations' corporate or business travel programs. Such companies will often provide an end-user online booking tool, mobile application, program management, and consulting teams, executive travel services, meetings and events support, reporting functionality, duty of care, and more. Non-Profit travel management companies also provide services to manage complex visa requirements, pre-trip medical needs, remote area travel, ...
ATR vs GBTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $792.0M |
| Net Profit | $74.3M | $83.0M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 3.7% |
| Net Margin | 7.7% | 10.5% |
| Revenue YoY | 13.5% | 34.0% |
| Net Profit YoY | -26.4% | 692.9% |
| EPS (diluted) | $1.13 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $792.0M | ||
| Q3 25 | $961.1M | $674.0M | ||
| Q2 25 | $966.0M | $631.0M | ||
| Q1 25 | $887.3M | $621.0M | ||
| Q4 24 | $848.1M | $591.0M | ||
| Q3 24 | $909.3M | $597.0M | ||
| Q2 24 | $910.1M | $625.0M | ||
| Q1 24 | $915.4M | $610.0M |
| Q4 25 | $74.3M | $83.0M | ||
| Q3 25 | $127.9M | $-62.0M | ||
| Q2 25 | $111.7M | $15.0M | ||
| Q1 25 | $78.8M | $75.0M | ||
| Q4 24 | $100.9M | $-14.0M | ||
| Q3 24 | $100.0M | $-128.0M | ||
| Q2 24 | $90.5M | $27.0M | ||
| Q1 24 | $83.1M | $-19.0M |
| Q4 25 | 11.0% | 3.7% | ||
| Q3 25 | 14.2% | 1.8% | ||
| Q2 25 | 14.9% | 5.4% | ||
| Q1 25 | 12.8% | 8.9% | ||
| Q4 24 | 14.2% | 5.1% | ||
| Q3 24 | 15.2% | 4.5% | ||
| Q2 24 | 13.8% | 6.7% | ||
| Q1 24 | 12.2% | 2.6% |
| Q4 25 | 7.7% | 10.5% | ||
| Q3 25 | 13.3% | -9.2% | ||
| Q2 25 | 11.6% | 2.4% | ||
| Q1 25 | 8.9% | 12.1% | ||
| Q4 24 | 11.9% | -2.4% | ||
| Q3 24 | 11.0% | -21.4% | ||
| Q2 24 | 9.9% | 4.3% | ||
| Q1 24 | 9.1% | -3.1% |
| Q4 25 | $1.13 | $0.16 | ||
| Q3 25 | $1.92 | $-0.13 | ||
| Q2 25 | $1.67 | $0.03 | ||
| Q1 25 | $1.17 | $0.16 | ||
| Q4 24 | $1.48 | $-0.04 | ||
| Q3 24 | $1.48 | $-0.28 | ||
| Q2 24 | $1.34 | $0.06 | ||
| Q1 24 | $1.23 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $434.0M |
| Total DebtLower is stronger | $1.1B | $1.4B |
| Stockholders' EquityBook value | $2.7B | $1.6B |
| Total Assets | $5.3B | $4.9B |
| Debt / EquityLower = less leverage | 0.43× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $434.0M | ||
| Q3 25 | $264.8M | $427.0M | ||
| Q2 25 | $169.8M | $601.0M | ||
| Q1 25 | $136.8M | $552.0M | ||
| Q4 24 | $226.2M | $536.0M | ||
| Q3 24 | $327.9M | $524.0M | ||
| Q2 24 | $223.9M | $515.0M | ||
| Q1 24 | $201.1M | $475.0M |
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $546.0M | $1.4B | ||
| Q2 25 | $535.1M | $1.4B | ||
| Q1 25 | $561.2M | $1.4B | ||
| Q4 24 | $688.1M | $1.4B | ||
| Q3 24 | $822.7M | $1.4B | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $1.6B | ||
| Q3 25 | $2.8B | $1.5B | ||
| Q2 25 | $2.7B | $1.2B | ||
| Q1 25 | $2.5B | $1.1B | ||
| Q4 24 | $2.5B | $1.1B | ||
| Q3 24 | $2.5B | $1.1B | ||
| Q2 24 | $2.4B | $1.2B | ||
| Q1 24 | $2.3B | $1.2B |
| Q4 25 | $5.3B | $4.9B | ||
| Q3 25 | $5.1B | $4.8B | ||
| Q2 25 | $4.9B | $3.9B | ||
| Q1 25 | $4.5B | $3.8B | ||
| Q4 24 | $4.4B | $3.6B | ||
| Q3 24 | $4.6B | $3.8B | ||
| Q2 24 | $4.5B | $3.8B | ||
| Q1 24 | $4.4B | $3.8B |
| Q4 25 | 0.43× | 0.88× | ||
| Q3 25 | 0.20× | 0.91× | ||
| Q2 25 | 0.20× | 1.15× | ||
| Q1 25 | 0.22× | 1.23× | ||
| Q4 24 | 0.28× | 1.32× | ||
| Q3 24 | 0.32× | 1.26× | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $52.0M |
| Free Cash FlowOCF − Capex | $96.9M | $13.0M |
| FCF MarginFCF / Revenue | 10.1% | 1.6% |
| Capex IntensityCapex / Revenue | 9.0% | 4.9% |
| Cash ConversionOCF / Net Profit | 2.47× | 0.63× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $104.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $52.0M | ||
| Q3 25 | $177.6M | $71.0M | ||
| Q2 25 | $126.0M | $57.0M | ||
| Q1 25 | $82.7M | $53.0M | ||
| Q4 24 | $178.2M | $65.0M | ||
| Q3 24 | $229.3M | $85.0M | ||
| Q2 24 | $143.6M | $73.0M | ||
| Q1 24 | $92.3M | $49.0M |
| Q4 25 | $96.9M | $13.0M | ||
| Q3 25 | $114.3M | $38.0M | ||
| Q2 25 | $62.5M | $27.0M | ||
| Q1 25 | $25.9M | $26.0M | ||
| Q4 24 | $112.2M | $33.0M | ||
| Q3 24 | $162.7M | $59.0M | ||
| Q2 24 | $75.4M | $49.0M | ||
| Q1 24 | $16.7M | $24.0M |
| Q4 25 | 10.1% | 1.6% | ||
| Q3 25 | 11.9% | 5.6% | ||
| Q2 25 | 6.5% | 4.3% | ||
| Q1 25 | 2.9% | 4.2% | ||
| Q4 24 | 13.2% | 5.6% | ||
| Q3 24 | 17.9% | 9.9% | ||
| Q2 24 | 8.3% | 7.8% | ||
| Q1 24 | 1.8% | 3.9% |
| Q4 25 | 9.0% | 4.9% | ||
| Q3 25 | 6.6% | 4.9% | ||
| Q2 25 | 6.6% | 4.8% | ||
| Q1 25 | 6.4% | 4.3% | ||
| Q4 24 | 7.8% | 5.4% | ||
| Q3 24 | 7.3% | 4.4% | ||
| Q2 24 | 7.5% | 3.8% | ||
| Q1 24 | 8.3% | 4.1% |
| Q4 25 | 2.47× | 0.63× | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | 3.80× | ||
| Q1 25 | 1.05× | 0.71× | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | 2.70× | ||
| Q1 24 | 1.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
GBTG
| Travel | $620.0M | 78% |
| Other | $172.0M | 22% |
